In this study, we found the first evidence that PTPRD levels are significantly lower in patient with T2D, that this protein is involved in the insulin signaling pathway, and that it can be epigenetically silenced by DNA methylation. This evidence concerns the gene PTPRD and type 2 diabetes mellitus.